Extracorporeal Shockwave therapy for intermittent claudication 1.0
Research type
Research Study
Full title
Extracorporeal Shockwave therapy in lower limb intermittent claudication. A randomised clinical trial comparing extracorporeal shockwave therapy with conservative management for lower limb intermittent claudication
IRAS ID
166137
Contact name
Ian Chetter
Contact email
Sponsor organisation
Hull and East Yorkshire Hospital Trust
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Peripheral arterial disease is a common condition affecting approximately 64% of 56-77 year olds. This condition restricts bloody supply to calf muscles. Pain occurs after walking a short distance and increases in intensity until the person stops, where the pain then gradually subsides. It can be limiting or occasionally debilitating and has been shown to have considerable deleterious effects of patients quality of life. Shock wave therapy has been shown to promote new blood vessel formation and improved healing amongst other findings. This study aims to identify whether shock wave therapy that is applied to the calf muscles causes such an effect to improve the blood supply to the calf muscles, reduce pain, improve walking ability and quality of life.
REC name
East of England - Cambridge East Research Ethics Committee
REC reference
14/EE/1257
Date of REC Opinion
10 Mar 2015
REC opinion
Further Information Favourable Opinion